Related Research Articles
GSK plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. The company focused on product development activities on viruses and human disease, including those caused by cytomegalovirus (CMV) and hepatitis C virus (HCV) infections. It was purchased by Shire in 2013, with Shire paying around $4.2 billion for the company in a deal that was finalized in January 2014. ViroPharma was a member of the NASDAQ Biotechnology Index and the S&P 600.
Sir Philip Roy Hampton is a British businessman. He was the first chairman of UK Financial Investments Limited in 2008 and chairman of government-owned The Royal Bank of Scotland Group between 2009 and 2015. He has also chaired GlaxoSmithKline and J Sainsbury.
Sir Andrew Philip Witty is a British business executive, who is the chief executive officer (CEO) of UnitedHealth Group. He was the CEO of GlaxoSmithKline between 2008 and 2017. He formerly held the role of chancellor of the University of Nottingham.
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, USA, and Genmab K.K. in Tokyo, Japan. Genmab is a dual-listed company with shares traded on both the Copenhagen Stock Exchange in Denmark and the NASDAQ Global Select Market in the US.
The National Health Council (NHC) is a nonprofit association of health organizations.
Cambridge Antibody Technology was a biotechnology company headquartered in Cambridge, England, United Kingdom. Its core focus was on antibody therapeutics, primarily using Phage Display and Ribosome Display technology.
Michelle Dipp is an American scientist, businesswoman, and investor. She is the co-founder and a managing partner at Biospring Partners and serves on the board of Abzena and Kiniciti.
The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.
The pharmaceutical industry in Pakistan is strictly regulated by the Drug Regulatory Authority of Pakistan, which oversees drug approvals and pricing.
OncoMed Pharmaceuticals, Inc. was a public American pharmaceutical development company headquartered in Redwood City, California. The company was founded in August 2004 by two University of Michigan investigators, Michael Clarke and Max S. Wicha. As of 2013, the company had 83 employees. OncoMed's drug discovery work focuses on developing "targeted antibodies against cancer stem cells". The cancer stem cell technologies on which OncoMed depends are licensed from the University of Michigan where they were developed by the founders of the company. OncoMed went public in 2013 and was listed on NASDAQ under the stock symbol OMED. In April 2019 the company was acquired by Mereo BioPharma and delisted from the Nasdaq.
The Institute for Clinical and Economic Review (ICER) is a Boston-based independent nonprofit organization that seeks to place a value on medical care by providing comprehensive clinical and cost-effectiveness analyses of treatments, tests, and procedures.
Dame Emma Natasha Walmsley is the chief executive officer (CEO) of GlaxoSmithKline. She succeeded Sir Andrew Witty, who retired in March 2017. Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. She grew up in Barrow-in-Furness, Cumbria, England.
Brad Mitchell is an American businessman and was the founding President and CEO of ChainDrugStore.net from 2000 to 2005. He prepared the company for a management-led buyout with a private investor in early 2006. His public service includes serving on the White House Staff of President George H.W. Bush (41) and as a policy adviser in President Bush's 1988 Presidential campaign. Additionally, he led the presidential transition teams for the National Aeronautics and Space Administration (NASA), the White House Office of Science and Technology Policy and the National Science Foundation. Mitchell is Founder and board chairman of the National Athletic and Professional Success Academy (NAPSA); President of Pinnacle Summit Services and The Mitchell Group, a consulting and executive leadership coaching firm; and a certified executive leadership coach (PCC), International Coaching Federation (ICF) specializing in coaching successful leaders and executive teams to elevate their performance. Mitchell previously served as President of S4 Consulting, Chief Commercial Officer of AccuWeather Enterprise Solutions, and Senior Vice President and Chief Marketing Officer of DrugEmporium.com. He holds degrees from The Pennsylvania State University and Harvard University. Mitchell is a retired Lieutenant in the United States Naval Reserve.
Paul-Peter Tak M.D. PhD FMedSci is an immunologist and academic specialising in the fields of internal medicine, rheumatology and immunology. Tak has been the President & CEO of Candel Therapeutics since September 2020.
Namal Nawana is an Australian businessman, and former chief executive (CEO) of Smith & Nephew plc, a British multinational medical equipment manufacturing company.
Linus Wang'ombe Gitahi is a Kenyan businessman and executive. He served as the Managing Director of GlaxoSmithKline Consumer Nigeria Plc, and the Group Chief Executive Officer of Nation Media Group. He currently serves as the Chairman of the Boards of Home Afrika, Diamond Trust Bank Group, AIB Capital Ltd, Oxygene Communications Limited, and Tropikal Brands (Afrika) Limited. He is a member of the boards of Simba Corp, Brand Kenya Board, Property Development & Management Ltd, International Press Institute, African Media Initiative, and Allianz Insurance Co. of Kenya Ltd. He is the founder of Baraka Foundation.
Moncef Mohamed Slaoui is a Moroccan-born Belgian-American researcher who served as the head of Operation Warp Speed (OPWASP) under President Donald Trump from 2020 to 2021.
References
- ↑ "With great sadness we wish to inform you that Olivier Bohuon passed away on Sunday" . Retrieved 2024-05-07.
- 1 2 3 4 "BOHUON, Olivier Jean". Who's Who 2017. Oxford University Press. Retrieved 11 September 2017.
- ↑ "The business on...Olivier Bohuon, Chief executive, Smith & Nephew". The Independent. 5 November 2011. Retrieved 21 November 2012.
- ↑ "Namal Nawana appointed Chief Executive Officer of Smith & Nephew | Smith & Nephew". www.smith-nephew.com. Retrieved 2018-10-03.
- ↑ "Olivier Bohuon: Executive Profile". BusinessWeek. Retrieved 21 November 2012.[ dead link ]
- ↑ "Olivier Bohuon Elected to LEO Pharma's Board of Directors" . Retrieved 2018-10-03.
- ↑ Brown, John Murray (February 1, 2016). "Smith & Nephew chief Olivier Bohuon has 'highly treatable' cancer". Financial Times. Retrieved 11 September 2017.
- ↑ Bradshaw, Julia (1 February 2016). "Smith & Nephew boss reveals cancer diagnosis". The Daily Telegraph. Retrieved 11 September 2017.
 | This French business–related biographical article is a stub. You can help Wikipedia by expanding it. |